1986
DOI: 10.1021/jm00156a023
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and .alpha.-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents

Abstract: Various kinds of N-substituted valiolamine derivatives, including compounds 23a, 24a, and 34a, which are structurally analogous to the key pseudodisaccharides (25a and 26a) of naturally occurring oligosaccharide alpha-D-glucosidase inhibitors, have been synthesized and estimated by the measure of inhibitory activity against porcine sucrase and maltase. The N-substituted valiolamine derivatives evaluated in this study have been found to be more potent than the corresponding N-substituted valienamine derivatives… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
165
0
3

Year Published

1998
1998
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 322 publications
(170 citation statements)
references
References 5 publications
1
165
0
3
Order By: Relevance
“…This action may pose an advantage over synthetic drugs presently in use for the management of postprandial blood glucose, such as acarbose, which strongly inhibit α-amylase. There are indications that excessive pancreatic amylase inhibition could result into abnormal bacterial fermentation of undigested saccharides in the colon (Horii et al, 1986;Bischoff, 1994). Hence, stronger inhibition of α-glucosidase activity and mild inhibition of α-amylase activity of the spice extracts could minimize the major setback of currently used α-glucosidase and α-amylase inhibitory drugs with side effects such as abdominal distention, flatulence, meteorism and possibly diarrhea (Bischoff, 1994).…”
Section: Resultsmentioning
confidence: 99%
“…This action may pose an advantage over synthetic drugs presently in use for the management of postprandial blood glucose, such as acarbose, which strongly inhibit α-amylase. There are indications that excessive pancreatic amylase inhibition could result into abnormal bacterial fermentation of undigested saccharides in the colon (Horii et al, 1986;Bischoff, 1994). Hence, stronger inhibition of α-glucosidase activity and mild inhibition of α-amylase activity of the spice extracts could minimize the major setback of currently used α-glucosidase and α-amylase inhibitory drugs with side effects such as abdominal distention, flatulence, meteorism and possibly diarrhea (Bischoff, 1994).…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, an inhibitor of intestinal a-glucosidase could be expected to retard carbohydrate digestion and absorption. Potent a-glucosidase inhibitors such as acarbose 1) and voglibose 2) have already been clinically used as medicines for diabetic and obese patients.…”
mentioning
confidence: 99%
“…Conversely, valiolamine (34) has more potent -glucosidase inhibitory activity against porcine intestinal sucrase, maltase, and isomaltase than the rest of the aminocarbasugars [311]. This is why series of N-substituted valiolamines were synthesized, resulting in the preparation of the glycohydrolase inhibitor voglibose (48) [312][313][314]. Voglibose was launched as an antidiabetic agent in 1994 to improve postprandial hyperglycemia in diabetes mellitus [315][316][317][318].…”
Section: Aminocarbasugars Aminocarbasugarsmentioning
confidence: 99%